EIF6 and acute myeloid leukemia: We already postulated that the presence of del (20)(q), with the loss of the EIF6 gene, results in more efficient ribosome biogenesis and implies both a lower risk of MDS/AML [7] and a milder haematological condition compared to SDS patients without del (20)(q) [8, 9].